This message was sent to ##Email##
Advertisement
|
|
|
|
| |
National Minority Donor Awareness Week, observed during the first week of August, seeks to heighten awareness of the need for donation and transplantation in minority communities.
During National Minority Donor Awareness Week, the Health Resources and Services Administration (HRSA) invites you to learn about organ, eye, and tissue donation and why we’re all needed. To learn more and sign up, visit organdonor.gov or donaciondeorganos.gov. We also invite you to “like” Organdonor.gov and Donaciondeorganos.gov on Facebook.
 Dear ITNS Members,
I appreciate this opportunity to share with you some of the incredible successes of the past few months.
First, the Board, staff and dedicated volunteers are deep into preparations for our 2019 Annual Symposium. The strategic priority of ITNS, “to provide relevant evidence-based education for transplant nurses,” has never been stronger and our efforts are unwavering. Our commitment to education for transplant nurses around the world is uncompromising. “Transplant Nursing in the 21st Century: A Universal Code for Care” is this year’s conference theme. Ms. Linda Ohler and Anna Sorenson are spearheading a forward-thinking planning committee, in building a program of dynamic speakers and thought leaders who will bring information on state-of-the-art tactics in transplant care.
READ MORE
Don’t miss Dr. Coleman’s Keynote Address, Omics and Transplantation: A Paradigm Shift in Transplant Nursing – Are We Ready? at the ITNS Symposium. Register before Oct. 16 to save $100! Learn more and register today!
 The A Guide to Your Healthcare After Lung Transplantation handbook is designed as a general reference for care after lung transplantation. It provides important information for the patient and their family as they prepare for discharge from the hospital.
ITNS members can download the Patient Education booklets for free on the ITNS website.
Hospital Use of Patient Education Booklets: If you would like to print copies of this patient education booklet for distribution at your hospital, we sell the print-ready file in the ITNS Online Store. The listing is to purchase unrestricted permission to photocopy or print a patient education handbook for educational use.
Thank you to the Lung Transplant Foundation for their support of this handbook.
The OPTN is seeking feedback on initiatives impacting organ donation and transplantation in the U.S. The public comment period for the proposals below will be open from August 2, 2019 to October 2, 2019. Please review the proposals and submit your approval/support, disapproval/lack of support, or suggestions on the OPTN website (https://optn.transplant.hrsa.gov/governance/public-comment/).
 |
|
Promoted by
Veloxis Pharmaceuticals
Follow the journeys of kidney transplant patients who transitioned to a different immunosuppression regimen. After talking with their doctors about their experiences with other options, they decided to make a switch.
Watch video
|
|
| Location |
Job Title |
More Information |
Memphis, TN
|
RN
|
More info |
Lake Charles, LA
|
CNA - Inpatient Rehab
|
More info |
Danville, PA
|
Nursing Assistant
|
More info |
|
Chicago North Lake, IL |
Registered Nurse
|
More info |
Michigan Health
The lighted screen of a smart phone has become a beacon for potential and current kidney and liver transplant patients and their supporters.
Michigan Medicine Transplant Center has developed two free apps — one for kidney transplant education, the other, liver transplant education — that shed light on how to navigate the complex transplant journey. They include lessons on everything from the tests required to be placed on the donor waitlist to what medicines prevent rejection and everything in between.
READ MORE
Advertisement
Veloxis Pharmaceuticals
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Learn More
|
King's College London via ScienceDaily
Researchers at King's College London have used single cell RNA sequencing to identify a type of cell that may be able to regenerate liver tissue, treating liver failure without the need for transplants.
In a paper published in Nature Communications, the scientists have identified a new type of cell, called a hepatobiliary hybrid progenitor, that forms during our early development in the womb. Surprisingly, HHyP also persist in small quantities in adults, and these cells can grow into the two main cell types of the adult liver, giving HHyPs stem cell like properties.
READ MORE
Huffington Post
Heart disease is the top cause of death in the U.S. For some people with end-stage heart disease, a heart transplant can save their life. Unfortunately, there are currently more patients on the heart transplant list than there are suitable donors. As a result, half of the patients on the heart transplant list wait for over a year. Some will die without ever getting a heart. Today, 40 percent of Americans can be classified as obese. Almost eight percent fall into the category of severe obesity, which is a body mass index greater than 40. These numbers have increased significantly since 2003 and are still going up. Many heart transplant centers require that heart transplant recipients keep their BMI at 35 or less. As the donor pool becomes increasingly overweight, our concern is that severely obese donors may get overlooked, because of the mismatch between the donor and recipient weights.
READ MORE
Cancer
Solid organ transplant recipients have an increased cancer risk compared with the general population. Excess risk varies by cancer type and is largely due to immunosuppression from medications used to prevent rejection, underlying medical comorbidities, and end-stage organ disease. Recipients have an elevated risk of both virus-related cancers (eg, non-Hodgkin lymphoma [NHL], caused by Epstein-Barr virus [EBV]) and virus-unrelated cancers (eg, lung and kid-ney cancers). Moreover, the transplant population in the United States has doubled since the late 1980s due to an increasing number of transplantations and improved survival. Understanding long-term health risks, including cancer, is critical.
READ MORE
AJT
Donor infection or colonization with a multidrug‐resistant organism affects organ utilization and recipient antibiotic management. Approaches to identifying donors at risk of carrying MDROs are unknown. Researchers sought to determine the risk factors for MDROs among transplant donors.
READ MORE
Journal of Hepatology
Little is known about outcomes of liver transplantation for patients with non-alcoholic steatohepatitis. Researchers aimed to determine the frequency and outcomes of liver transplantation for patients with NASH in Europe and identify prognostic factors.
READ MORE
AASLD
Data on postoperative chylous ascites after pediatric liver transplantation are scarce. This retrospective study was conducted to identify the incidence, risk factors, management, and outcome of postoperative CA in a large single‐center pediatric LT cohort.
READ MORE
The Lancet Gastroenterology & Hepatology
Low donor heart availability underscores the need to identify all potentially transplantable organs. Researchers sought to determine whether pre-emptive administration of pangenotypic direct-acting antiviral therapy can safely prevent the development of chronic hepatitis C virus infection in uninfected recipients of HCV-infected donor hearts.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
